BlackRock Inc. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 156 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$115,112,525
-14.0%
4,651,011
-1.6%
0.00%
-25.0%
Q2 2023$133,848,080
+21.0%
4,726,274
-1.9%
0.00%
+33.3%
Q1 2023$110,648,214
-17.4%
4,817,075
+1.0%
0.00%
-25.0%
Q4 2022$133,909,982
-1.2%
4,768,874
-0.5%
0.00%
-20.0%
Q3 2022$135,503,000
+26.3%
4,791,542
-1.0%
0.01%
+66.7%
Q2 2022$107,258,000
-29.2%
4,838,013
-7.0%
0.00%
-25.0%
Q1 2022$151,430,000
-14.8%
5,201,940
-3.8%
0.00%
-20.0%
Q4 2021$177,779,000
-33.1%
5,408,536
-6.1%
0.01%
-28.6%
Q3 2021$265,691,000
-19.3%
5,757,127
-3.6%
0.01%
-22.2%
Q2 2021$329,256,000
+36.2%
5,974,507
+27.7%
0.01%
+28.6%
Q1 2021$241,669,000
+24.4%
4,679,900
+4.3%
0.01%
+16.7%
Q4 2020$194,335,000
+15.8%
4,485,000
-6.5%
0.01%0.0%
Q3 2020$167,829,000
-37.3%
4,795,138
-4.2%
0.01%
-45.5%
Q2 2020$267,764,000
+66.6%
5,006,831
+10.5%
0.01%
+37.5%
Q1 2020$160,709,000
-13.6%
4,529,580
+16.3%
0.01%
+14.3%
Q4 2019$185,908,000
+97.0%
3,893,394
+33.7%
0.01%
+75.0%
Q3 2019$94,375,000
-56.6%
2,912,783
-33.2%
0.00%
-55.6%
Q2 2019$217,585,000
-3.2%
4,362,184
+30.8%
0.01%
-10.0%
Q1 2019$224,869,000
+46.7%
3,334,365
+0.3%
0.01%
+25.0%
Q4 2018$153,292,000
-39.5%
3,324,479
+1.2%
0.01%
-27.3%
Q3 2018$253,404,000
-7.4%
3,285,842
+1.2%
0.01%
-15.4%
Q2 2018$273,601,000
+4.4%
3,248,251
+1.3%
0.01%0.0%
Q1 2018$262,192,000
+63.1%
3,206,053
+14.0%
0.01%
+62.5%
Q4 2017$160,803,000
-16.1%
2,812,717
-2.1%
0.01%
-20.0%
Q3 2017$191,682,000
+39.3%
2,871,626
+7.3%
0.01%
+42.9%
Q2 2017$137,648,000
+8.8%
2,675,380
+23.5%
0.01%0.0%
Q1 2017$126,556,000
+11873.1%
2,167,074
+8463.5%
0.01%
+600.0%
Q4 2016$1,057,000
-63.8%
25,306
-54.2%
0.00%
-75.0%
Q3 2016$2,920,000
+101.7%
55,279
+60.0%
0.00%
+100.0%
Q2 2016$1,448,000
+898.6%
34,560
+859.5%
0.00%
Q1 2016$145,000
+195.9%
3,602
+373.3%
0.00%
Q4 2015$49,000
+19.5%
761
+31.4%
0.00%
Q3 2015$41,000
-45.3%
579
-14.1%
0.00%
Q2 2015$75,000
-97.2%
674
-97.6%
0.00%
-100.0%
Q1 2015$2,661,000
-14.3%
28,215
+1.8%
0.00%0.0%
Q4 2014$3,105,000
+83.9%
27,715
+0.7%
0.00%
+100.0%
Q3 2014$1,688,000
-41.5%
27,515
-56.3%
0.00%
-50.0%
Q2 2014$2,887,000
+35987.5%
63,009
+32212.3%
0.00%
Q1 2014$8,000
+100.0%
195
+27.5%
0.00%
Q4 2013$4,0000.0%1530.0%0.00%
Q3 2013$4,0001530.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders